Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
6.160USD
+0.210+3.53%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.18BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
14.02%
GSK plc
9.48%
Fidelity Management & Research Company LLC
7.10%
BlackRock Institutional Trust Company, N.A.
5.21%
Adage Capital Management, L.P.
5.09%
Other
59.11%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
14.02%
GSK plc
9.48%
Fidelity Management & Research Company LLC
7.10%
BlackRock Institutional Trust Company, N.A.
5.21%
Adage Capital Management, L.P.
5.09%
Other
59.11%
Shareholder Types
Shareholders
Proportion
Investment Advisor
34.60%
Hedge Fund
22.19%
Investment Advisor/Hedge Fund
18.68%
Corporation
15.45%
Venture Capital
14.10%
Research Firm
1.78%
Individual Investor
0.43%
Bank and Trust
0.31%
Pension Fund
0.18%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
342
144.00M
77.83%
--
2026Q1
433
180.16M
93.64%
+29.09M
2025Q4
393
146.58M
80.21%
+2.16M
2025Q3
368
140.86M
88.47%
+5.01M
2025Q2
364
156.69M
98.46%
-1.61M
2025Q1
368
156.82M
101.38%
+1.16M
2024Q4
342
152.89M
100.27%
+6.14M
2024Q3
306
144.44M
97.59%
+25.71M
2024Q2
274
116.00M
94.13%
+429.46K
2024Q1
255
115.83M
95.69%
+2.66M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
26.99M
14.34%
+8.79M
+48.28%
Mar 30, 2026
GSK plc
18.25M
9.69%
+1.47M
+8.76%
Dec 31, 2025
Fidelity Management & Research Company LLC
13.65M
7.25%
+9.36M
+218.18%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.02M
5.32%
+1.29M
+14.77%
Dec 31, 2025
Adage Capital Management, L.P.
9.79M
5.2%
-4.78M
-32.82%
Dec 31, 2025
Shin Nippon Biomedical Laboratories Ltd
5.71M
3.03%
--
--
Jun 06, 2025
Maverick Capital, Ltd.
9.28M
4.93%
+888.38K
+10.59%
Dec 31, 2025
Darwin Global Management Ltd
7.30M
3.88%
+7.30M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
7.26M
3.86%
+3.35M
+85.76%
Dec 31, 2025
Driehaus Capital Management, LLC
6.58M
3.5%
+283.01K
+4.49%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Pharmaceuticals ETF
1.81%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.34%
Global X Genomics & Biotechnology ETF
1.25%
Virtus LifeSci Biotech Clinical Trials ETF
0.85%
iShares U.S. Pharmaceuticals ETF
0.41%
First Trust Multi-Manager Small Cap Opportunities ETF
0.26%
iShares Micro-Cap ETF
0.19%
Franklin Genomic Advancements ETF
0.19%
ProShares Ultra Nasdaq Biotechnology
0.15%
Invesco Nasdaq Biotechnology ETF
0.14%
View more
State Street SPDR S&P Pharmaceuticals ETF
Proportion1.81%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion1.34%
Global X Genomics & Biotechnology ETF
Proportion1.25%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.85%
iShares U.S. Pharmaceuticals ETF
Proportion0.41%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.26%
iShares Micro-Cap ETF
Proportion0.19%
Franklin Genomic Advancements ETF
Proportion0.19%
ProShares Ultra Nasdaq Biotechnology
Proportion0.15%
Invesco Nasdaq Biotechnology ETF
Proportion0.14%
